Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 114

Results For "Head"

1966 News Found

CAHO and Dozee join hands to discuss emerging role of AI in healthcare
Digitisation | March 30, 2023

CAHO and Dozee join hands to discuss emerging role of AI in healthcare

70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai


Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
News | March 29, 2023

Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare

The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies


Sanofi receives marketing approval for its diabetes drug Soliqua in India
Drug Approval | March 29, 2023

Sanofi receives marketing approval for its diabetes drug Soliqua in India

Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing


PM to address One World TB Summit tomorrow
News | March 23, 2023

PM to address One World TB Summit tomorrow

PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB


Investment in healthcare workforce key to accelerating India’s economic growth: Experts
Healthcare | March 23, 2023

Investment in healthcare workforce key to accelerating India’s economic growth: Experts

Integration of modern and traditional medicine to facilitate the illness to wellness journey


Lupin receives approval from USFDA for Brexpiprazole Tablets
Drug Approval | March 22, 2023

Lupin receives approval from USFDA for Brexpiprazole Tablets

Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)


Zydus granted Orphan Drug Designation by USFDA for ZYIL1
Drug Approval | March 22, 2023

Zydus granted Orphan Drug Designation by USFDA for ZYIL1

ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates


Patritumab Deruxtecan shows better clinical activity in patient with lung and breast cancer
Clinical Trials | March 20, 2023

Patritumab Deruxtecan shows better clinical activity in patient with lung and breast cancer

Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session


Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data
News | March 20, 2023

Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans